Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 7 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2018 Filed Mar 9, 2018 23:00 UTC |
Hughes Thomas E.Director · See Remarks
|
SaleCommon Stock | 5,000 | $10.00 | $50,000.00 |
DisclosureSEC source: 0000899243-18-006980 · doc4.xml · nonDerivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,247 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 17:06 UTC |
KIM DENNIS DChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0000899243-18-005337 · doc4.xml · derivative · entry 1 KIM DENNIS D · CIK 0001456750 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-02-22 F1 · derivative.exercise_date: 25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 22:00 UTC |
Allen Patricia LChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0000899243-18-005331 · doc4.xml · derivative · entry 1 Allen Patricia L · CIK 0001348587 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-02-22 F1 · derivative.exercise_date: 25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 22:00 UTC |
Hatfield Jeffrey S.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 275,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0000899243-18-005333 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2028-02-22 F1 · derivative.exercise_date: 25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 22:00 UTC |
Hughes Thomas E.Director · See Remarks
|
GrantStock Option (right to buy) · Derivative | 275,000 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0000899243-18-005332 · doc4.xml · derivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2028-02-22 F1 · derivative.exercise_date: 25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:59 UTC |
Booth BruceDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 8,509 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0000899243-18-000593 · doc4.xml · derivative · entry 1 Booth Bruce · CIK 0001451612 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,509 Underlying: Common Stock · 8,509 shares Expires 2028-01-03 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2018 on a quarterly basis in arrears. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 22:01 UTC |
Barrett PeterDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 17,627 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0000899243-18-000594 · doc4.xml · derivative · entry 1 Barrett Peter · CIK 0001291895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,627 Underlying: Common Stock · 17,627 shares Expires 2028-01-03 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2018 on a quarterly basis in arrears. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:59 UTC |
PEREZ ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,421 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0000899243-18-000591 · doc4.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,421 Underlying: Common Stock · 9,421 shares Expires 2028-01-03 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2018 on a quarterly basis in arrears. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 17:01 UTC |
LAMATTINA JOHN LDirector
|
GrantCommon Stock | 9,169 | $5.18 | $47,495.42 |
DisclosureSEC source: 0000899243-18-000595 · doc4.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,532 F1 · shares: The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on a quarterly basis in arrears. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 22:02 UTC |
Daniel Thomas ODirector
|
GrantCommon Stock | 8,687 | $5.18 | $44,998.66 |
DisclosureSEC source: 0000899243-18-000596 · doc4.xml · nonDerivative · entry 1 Daniel Thomas O · CIK 0001538894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,452 F1 · shares: The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on quarterly basis in arrears. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 21:59 UTC |
McDonough Cameron GeoffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 9,725 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0000899243-18-000592 · doc4.xml · derivative · entry 1 McDonough Cameron Geoffrey · CIK 0001579130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,725 Underlying: Common Stock · 9,725 shares Expires 2028-01-03 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2018 on a quarterly basis in arrears. Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 21:30 UTC |
Hatfield Jeffrey S.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,100,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0000899243-17-029728 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 1,100,000 shares Expires 2027-10-09 F1 · date: This option was granted on October 9, 2017, subject to vesting based on the Issuer's stock price appreciation and certain financial performance goals. The financial performance goals were waived on December 29, 2017 and therefore the option is deemed a reportable derivative security as of such date. F2 · derivative.exercise_date: The option vests and becomes exercisable based on the Issuer's common stock price during the two years after the first anniversary of the date of grant as follows: 25% of shares subject to the option vest after the stock price is equal to or greater than $10.00 per share for 20 consecutive trading days; and an additional 6.25% of the shares subject to the option vest for every additional $2.50 in stock price above $10.00 per share for 20 consecutive trading days. The option has been granted pursuant to an inducement award agreement outside of the company's 2014 Stock Option and Incentive Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4). Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 17:11 UTC |
Heller Frances KDirector
|
PurchaseCommon Stock | 10,000 | $3.90 | $38,988.00 |
DisclosureSEC source: 0000899243-17-024381 · doc4.xml · nonDerivative · entry 1 Heller Frances K · CIK 0001441724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,961 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.8645 to $3.92, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. F2 · balance_after: Total number of shares includes 7,961 shares of Common Stock acquired by the Reporting Person on December 31, 2012 that were not previously reported. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 22:13 UTC |
Hatfield Jeffrey S.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 550,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0000899243-17-024054 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2027-10-09 F1 · derivative.exercise_date: 25% of this option vests on October 9, 2018 and the remainder vests in equal monthly installments thereafter over a 3-year period. The option has been granted pursuant to an inducement award agreement outside of the company's 2014 Stock Option and Incentive Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4). Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 22:03 UTC |
Hughes Thomas E.Director · See Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 275,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0000899243-17-024049 · doc4.xml · derivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2027-10-09 F1 · derivative.exercise_date: The option vests and becomes exercisable based on the Issuer's common stock price during the two years after the first anniversary of the date of grant as follows: 25% of shares subject to the option vest after the stock price is equal to or greater than $10.00 per share for 20 consecutive trading days; and an additional 6.25% of the shares subject to the option vest for every additional $2.50 in stock price above $10.00 per share for 20 consecutive trading days. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 16:05 UTC |
KIM DENNIS DChief Medical Officer
|
PurchaseCommon Stock | 10,000 | $3.39 | $33,900.00 |
DisclosureSEC source: 0000899243-17-018210 · doc4.xml · nonDerivative · entry 1 KIM DENNIS D · CIK 0001456750 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,443 Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:10 UTC |
Booth BruceDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017079 · doc4.xml · derivative · entry 1 Booth Bruce · CIK 0001451612 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:07 UTC |
Heller Frances KDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017070 · doc4.xml · derivative · entry 1 Heller Frances K · CIK 0001441724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:08 UTC |
Barrett PeterDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017073 · doc4.xml · derivative · entry 1 Barrett Peter · CIK 0001291895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:07 UTC |
PEREZ ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017069 · doc4.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:09 UTC |
THOMAS FRANK EDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017076 · doc4.xml · derivative · entry 1 THOMAS FRANK E · CIK 0001242616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 16:09 UTC |
LAMATTINA JOHN LDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017077 · doc4.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:13 UTC |
Daniel Thomas ODirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017085 · doc4.xml · derivative · entry 1 Daniel Thomas O · CIK 0001538894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:12 UTC |
McDonough Cameron GeoffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,500 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0000899243-17-017084 · doc4.xml · derivative · entry 1 McDonough Cameron Geoffrey · CIK 0001579130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Underlying: Common Stock · 14,500 shares Expires 2027-06-21 F1 · derivative.exercise_date: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors. Read SEC document |
| May 11, 2017 Filed May 11, 2017 18:59 UTC |
KIM DENNIS DChief Medical Officer
|
PurchaseCommon Stock | 9,800 | $4.40 | $43,120.00 |
DisclosureSEC source: 0000899243-17-012901 · doc4.xml · nonDerivative · entry 2 KIM DENNIS D · CIK 0001456750 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,443 F1 · balance_after: Includes 646 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on January 1, 2015, 699 shares acquired under the Plan on July 1, 2015 and 98 shares acquired under the Plan on January 1, 2016. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 68,073 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · derivative · entry 6 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,073 shares Expires 2020-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,210 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · derivative · entry 5 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,210 shares Expires 2019-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy · Derivative | 18,928 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · derivative · entry 4 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,928 shares Expires 2018-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionCommon Stock | 68,073 | $0.82 | $55,819.86 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · nonDerivative · entry 3 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionCommon Stock | 6,210 | $0.75 | $4,657.50 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · nonDerivative · entry 2 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017. Read SEC document |
| May 11, 2017 Filed May 16, 2017 00:22 UTC |
Hughes Thomas E.Director · President and CEO
|
Exercise / conversionCommon Stock | 18,928 | $0.75 | $14,196.00 |
DisclosureSEC source: 0000899243-17-013254 · doc4.xml · nonDerivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017. Read SEC document |
| May 10, 2017 Filed May 11, 2017 18:59 UTC |
KIM DENNIS DChief Medical Officer
|
PurchaseCommon Stock | 200 | $4.40 | $880.00 |
DisclosureSEC source: 0000899243-17-012901 · doc4.xml · nonDerivative · entry 1 KIM DENNIS D · CIK 0001456750 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · balance_after: Includes 646 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on January 1, 2015, 699 shares acquired under the Plan on July 1, 2015 and 98 shares acquired under the Plan on January 1, 2016. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 01:17 UTC |
Booth BruceDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 12,003 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0000899243-17-004102 · doc4.xml · derivative · entry 1 Booth Bruce · CIK 0001451612 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,003 Underlying: Common Stock · 12,003 shares Expires 2027-02-13 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2017 on a quarterly basis in arrears. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 01:10 UTC |
Barrett PeterDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 24,864 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0000899243-17-004094 · doc4.xml · derivative · entry 1 Barrett Peter · CIK 0001291895 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,864 Underlying: Common Stock · 24,864 shares Expires 2027-02-13 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2017 on a quarterly basis in arrears. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 01:16 UTC |
PEREZ ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,289 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0000899243-17-004101 · doc4.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,289 Underlying: Common Stock · 13,289 shares Expires 2027-02-13 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2017 on a quarterly basis in arrears. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 20:07 UTC |
LAMATTINA JOHN LDirector
|
GrantCommon Stock | 11,363 | $4.18 | $47,497.34 |
DisclosureSEC source: 0000899243-17-004091 · doc4.xml · nonDerivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,363 F1 · shares: The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2017 on a quarterly basis in arrears. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 01:14 UTC |
Daniel Thomas ODirector
|
GrantCommon Stock | 10,765 | $4.18 | $44,997.70 |
DisclosureSEC source: 0000899243-17-004099 · doc4.xml · nonDerivative · entry 1 Daniel Thomas O · CIK 0001538894 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,765 F1 · shares: The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2017 on quarterly basis in arrears. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 01:12 UTC |
McDonough Cameron GeoffreyDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,718 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0000899243-17-004098 · doc4.xml · derivative · entry 1 McDonough Cameron Geoffrey · CIK 0001579130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,718 Underlying: Common Stock · 13,718 shares Expires 2027-02-13 F1 · derivative.exercise_date: The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2017 on a quarterly basis in arrears. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 17:31 UTC |
KIM DENNIS DChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,000 | $0.00 Strike: $4.05 | $0.00 |
DisclosureSEC source: 0000899243-17-002287 · doc4.xml · derivative · entry 1 KIM DENNIS D · CIK 0001456750 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: 25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 22:31 UTC |
Allen Patricia LChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 88,000 | $0.00 Strike: $4.05 | $0.00 |
DisclosureSEC source: 0000899243-17-002288 · doc4.xml · derivative · entry 1 Allen Patricia L · CIK 0001348587 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: 25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 22:32 UTC |
Hughes Thomas E.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 319,000 | $0.00 Strike: $4.05 | $0.00 |
DisclosureSEC source: 0000899243-17-002289 · doc4.xml · derivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,000 Underlying: Common Stock · 319,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: 25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 17:02 UTC |
Heller Frances KDirector
|
PurchaseCommon Stock | 10,000 | $3.23 | $32,290.00 |
DisclosureSEC source: 0000899243-16-036035 · doc4.xml · nonDerivative · entry 1 Heller Frances K · CIK 0001441724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.20 to $3.24, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of share purchases at each separate price within the ranges set forth herein. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:00 UTC |
Heller Frances KDirector
|
PurchaseCommon Stock | 10,000 | $3.54 | $35,434.00 |
DisclosureSEC source: 0000899243-16-033799 · doc4.xml · nonDerivative · entry 1 Heller Frances K · CIK 0001441724 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.53 to $3.56, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.